Navigation Links
Measurements fail to identify TB patients who could benefit from shorter treatment course
Date:6/30/2009

Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs in resource-limited settings with poor public health infrastructures.

Testing whether two simple clinical measurements might help identify which TB patients could benefit from shorter treatment, researchers at Case Western Reserve University and University Hospitals (UH) Case Medical Center report that these measurements failed to work in a study published online by the American Journal of Respiratory and Critical Care Medicine.

The two measurements were absence of a cavity (an abscess caused by TB) in the lungs (detected by chest X-ray) and failure to grow TB bacteria from the sputum once drug treatment was started (sputum culture conversion). The Phase III clinical trial involved TB patients in Uganda (Africa), Brazil (S. America) and the Philippines (Asia) and was conducted by the Tuberculosis Research Unit (TBRU) at Case Western Reserve University and UH Case Medical Center in Cleveland, the only National Institutes of Health supported TB unit in the U.S.

"We found that combining these two clinical measurements failed to select TB patients who could benefit from shorter drug treatment. TB patients receiving four months of TB treatment had their disease come back much more often than those who got six months of drug treatment," said W. Henry Boom, M.D., an infectious disease expert with Case Western Reserve University and UH Case Medical Center and Director of the TBRU. "This study points out the limitations of current clinical measures to identify the relatively small group of TB patients who respond poorly to standard drug treatment."

"To better identify risk factors for why treatment fails in a subset of TB patients will require novel approaches and further research so that we can determine
'/>"/>

Contact: Alicia Reale
Alicia.Reale@UHhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Measurements Poor for Assessing Clinical Trials With Children
2. Companies Utilize Variety of Metrics for Quality Measurements
3. Brain measurements could lead to better devices to move injured or artificial limbs
4. The Rasansky Law Firm Publishes Guide for Identifying, Preventing Childcare and Daycare Abuse
5. As college drinking problems rise, new studies identify effective prevention strategies
6. USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
7. Researchers identify 4 new targets for breast cancer
8. Researchers identify four new targets for breast cancer
9. UNC scientists identify growth factor as possible cancer drug target
10. Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer
11. Immunologists identify biochemical signals that help immune cells remember how to fight infection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...SCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManage...are the Air Alert forThursday,November2...nyothersolidfuel,bothindoorsandoutdoors. ,, "Co...tomorrow,"saidJackBroadbent,executiveofficeroftheA...ehealthoftheirneighborsandfellowcommunitymembersth...
(Date:11/25/2009)...discovery that grew out of a collaboration between...ffer hope to the nearly 10 million Americans who s...so known as hardening of the arteries, peripheral ...problem in which narrowed arteries reduce blood fl... flag for vascular disease, heart attack and strok...
(Date:11/25/2009)... Evaluation and treatment clinics to resum...tock (Vocus) November 25, 2009 -- Centegra Health ...and H1N1 vaccine shots at four Centegra Primary Ca...t of vaccine has arrived. The clinics are at CPC s...ry and will be open as follows: ,   Fr...
(Date:11/25/2009)...ov.25/PRNewswire/-- MISSIONSkincare ®isproudt...Jude.AspartofGNC,sannualSt.Jude ThanksandGiving ca...re,s new SUPER-C(TM)LipBalm willbedonatedtoSt.Ju...kea$1,$5or$10donationatcheckoutatoneoftheir5,000+r...1millionforSt.Judeduringtheir2009 ThanksandGiving ...
(Date:11/25/2009)...treat colorectal cancer also can reverse a rare st... therapy for the disease, researchers at Vanderbil...ntrier,s disease causes thickening of the stomach ..., as well as anemia and swelling in the feet and a...ed risk for gastric cancer. Previously, the only e...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...Apollo hospital in Ahmedabad is to collaborate wit...ncer center (CBCC), to start a new radiation thera...CC of US is to supply new radiation therapy machin...hin the hospital premises a separate unit that wil...
...ers are more prone to losing their eyesight later ... There are around 500,000 people in the UK with ... an estimated 54,000 people have the condition as ...MD Alliance UK, based on a survey of 1,023 British...
...ing modality has yet another discovery to its cred... called is a safe, non-surgical method of identify... accurate// and rapid way of diagnosing meningitis...erious brain infections such as abscesses and meni...
... report published by the Department of Veterans Af...control the cholesterol levels and provided a guid... not only bad for the heart and blood vessels, but...erol Education Month in USA, VA highlights screeni...
...Japanese Encephalitis epidemic continues to cause ...sed health officials are tight-lipped about the to...Pradesh government and yesterday admitted the drea...ical facilities in eastern Uttar Pradesh, where th...
...ents who come to the emergency room with cervical ...tected. In a study, which is published in the Ann... be useful to detect such injuries in patients ove...sible on regular x-rays. In fact, more than a thir...
Other Medicine News:Health News:High Cholesterol Can Be Controlled By Screening And Prevention 2
(Date:11/25/2009)... PRINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Phar...ticalcompanycommittedtodiscovering,developingandco...rtedfinancialresultsforthefiscalyearendedSeptember...onincash,cashequivalentsandshortterminvestments. ,...28 ,, Phase2bTrial ,, InlateNovember200...
(Date:11/25/2009)... EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGr...telara report,thefirstinamulti-phasesyndicatedmar...-Biotech,sStelara,fromproductlaunchthroughthefirst...squantitativeinformationfrom75uniqueDermatologists...sassesstrialanduseofStelara,obstaclestouse,typical...
(Date:11/25/2009)... COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Re...ream-likefoamthatstopsseverebleeding,wonfirstprize...theGlobalSecurityChallenge2009,companyofficialsann...omaroundtheworld,Remedium,steampitchedtheirinventi...choolofBusiness. ,, Remedium( www.remediumtechn...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2NIST scientists study how to stack the deck for organic solar power 13266 1NIST scientists study how to stack the deck for organic solar power 13266 2Aurora St Lukes Healing Garden Earns LEED Certification 53167 1Aurora St Lukes Healing Garden Earns LEED Certification 53167 2
...h;The drug levosimendan did not improve,survival f...compared with a more widely-used treatment for thi...he May 2 issue of, JAMA . , Acute decompensated he...zed by inability of the heart to maintain adequate...italization worldwide,but appropriate treatment i...
...uals Reported Consistent Pain-Free,Results From At...-- Patients who suffer from,migraines frequently c...ir dissatisfaction with their medicine. New data f...gational migraine therapy,Trexima, when taken earl...s, as well as a sustained pain- free response 2-24...
Other Medicine Technology:Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 4
Random Dot "E" SO-003
Randot SO-002
Emit® Phenytoin Assay
IMMULITE Phenytoin
Medicine Products: